These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30315231)

  • 1. Activation of NF-κB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes.
    Ping Z; Chen S; Hermans SJF; Kenswil KJG; Feyen J; van Dijk C; Bindels EMJ; Mylona AM; Adisty NM; Hoogenboezem RM; Sanders MA; Cremers EMP; Lindenbergh-Kortleve DJ; Samsom JN; van de Loosdrecht AA; Raaijmakers MHGP
    Leukemia; 2019 Feb; 33(2):536-541. PubMed ID: 30315231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy.
    Poon Z; Dighe N; Venkatesan SS; Cheung AMS; Fan X; Bari S; Hota M; Ghosh S; Hwang WYK
    Leukemia; 2019 Jun; 33(6):1487-1500. PubMed ID: 30575819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
    Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
    Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest.
    Gañán-Gómez I; Wei Y; Yang H; Pierce S; Bueso-Ramos C; Calin G; Boyano-Adánez Mdel C; García-Manero G
    PLoS One; 2014; 9(4):e93404. PubMed ID: 24690917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic Syndromes and Metabolism.
    Balaian E; Wobus M; Bornhäuser M; Chavakis T; Sockel K
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
    Fei C; Zhao Y; Guo J; Gu S; Li X; Chang C
    Eur J Haematol; 2014 Dec; 93(6):476-86. PubMed ID: 24889123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zhao Y; Wu D; Fei C; Guo J; Gu S; Zhu Y; Xu F; Zhang Z; Wu L; Li X; Chang C
    Haematologica; 2015 Feb; 100(2):194-204. PubMed ID: 25361944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory.
    Gars E; Yousry SM; Babu D; Kurzer JH; George TI; Gratzinger D
    Leuk Lymphoma; 2017 Jul; 58(7):1730-1732. PubMed ID: 27808583
    [No Abstract]   [Full Text] [Related]  

  • 10. MicroRNA-661 upregulation in myelodysplastic syndromes induces apoptosis through p53 activation and associates with decreased overall survival.
    Kang SH; Choi JS
    Leuk Lymphoma; 2019 Nov; 60(11):2779-2786. PubMed ID: 31056984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNAs of single hematopoietic stem and progenitor cells in healthy and dysplastic human bone marrow.
    Wu Z; Gao S; Zhao X; Chen J; Keyvanfar K; Feng X; Kajigaya S; Young NS
    Haematologica; 2019 May; 104(5):894-906. PubMed ID: 30545929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.
    Santamaría C; Muntión S; Rosón B; Blanco B; López-Villar O; Carrancio S; Sánchez-Guijo FM; Díez-Campelo M; Alvarez-Fernández S; Sarasquete ME; de las Rivas J; González M; San Miguel JF; Del Cañizo MC
    Haematologica; 2012 Aug; 97(8):1218-24. PubMed ID: 22371183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes.
    Zhao Z; Wang Z; Li Q; Li W; You Y; Zou P
    PLoS One; 2012; 7(9):e45675. PubMed ID: 23029178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Grosjean-Raillard J; Tailler M; Adès L; Perfettini JL; Fabre C; Braun T; De Botton S; Fenaux P; Kroemer G
    Oncogene; 2009 Feb; 28(8):1099-109. PubMed ID: 19079347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VCAM-1 expression on bone marrow stromal cells from patients with myelodysplastic syndromes.
    Lubkova ON; Tzvetaeva NV; Momotyuk KS; Belkin VM; Manakova TE
    Bull Exp Biol Med; 2011 May; 151(1):13-5. PubMed ID: 22442792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk.
    Fattizzo B; Giannotta JA; Barcellini W
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.
    Roversi FM; Lopes MR; Machado-Neto JA; Longhini AL; Duarte Ada S; Baratti MO; Palodetto B; Corrocher FA; Pericole FV; Campos Pde M; Favaro P; Traina F; Saad ST
    Stem Cells Dev; 2014 May; 23(10):1109-20. PubMed ID: 24410667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression.
    Borojevic R; Roela RA; Rodarte RS; Thiago LS; Pasini FS; Conti FM; Rossi MI; Reis LF; Lopes LF; Brentani MM
    Leuk Res; 2004 Aug; 28(8):831-44. PubMed ID: 15203281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic control of NF-κB-dependent FAS gene transcription during progression of myelodysplastic syndromes.
    Ettou S; Humbrecht C; Benet B; Billot K; d'Allard D; Mariot V; Goodhardt M; Kosmider O; Mayeux P; Solary E; Fontenay M
    Mol Cancer Res; 2013 Jul; 11(7):724-35. PubMed ID: 23604035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of c-Fos via Overexpression of miR-34a Results in Enhancement of TNF- Production by LPS in Neutrophils from Myelodysplastic Syndrome Patients.
    Shikama Y; Cao M; Ono T; Feng X; Noji H; Kimura H; Ogawa K; Suzuki Y; Ikeda K; Takeishi Y; Kimura J
    PLoS One; 2016; 11(8):e0158527. PubMed ID: 27513856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.